Abstract
The European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) recently introduced guidelines on the use of contrast enhanced ultrasound (CEUS). The so-called non-liver guidelines included clinical recommendations on the use of CEUS in pancreatic diseases. This article focuses on the application of endoscopic ultrasound in the evaluation of pancreatic neoplasia to highlight the importance of CEUS in daily routine.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
